Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000950170-25-006473·BB BIOTECH AG
Schedule 13G ownership disclosure
N/A
Common Stock · CUSIP: 78667J108
Event date: 2025-01-13
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- BB Biotech AG
Shares: 1,178,503 · Class: 1.9%
- Biotech Target N.V.
Shares: 1,178,503 · Class: 1.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-006473
- Form type
- SCHEDULE 13G/A
- Filer
- BB BIOTECH AG
- CIK
- CIK 924223
- Filed
- Jan 17, 2025
- Reporting period
- Jan 13, 2025
- Description
- Schedule 13G beneficial ownership